Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

α-Synuclein Regulates Iron Homeostasis via Preventing Parkin-Mediated DMT1 Ubiquitylation in Parkinson’s Disease Models
Mingxia Bi, Xixun Du, Qian Jiao, et al.
ACS Chemical Neuroscience (2020) Vol. 11, Iss. 11, pp. 1682-1691
Closed Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Ferroptosis and its potential role in the physiopathology of Parkinson’s Disease
Laura Mahoney‐Sanchez, Hind Bouchaoui, Scott Ayton, et al.
Progress in Neurobiology (2020) Vol. 196, pp. 101890-101890
Open Access | Times Cited: 359
Pharmacological Inhibition of Ferroptosis as a Therapeutic Target for Neurodegenerative Diseases and Strokes
Yumin Wang, Shuang Wu, Qiang Li, et al.
Advanced Science (2023) Vol. 10, Iss. 24
Open Access | Times Cited: 81
The mechanism of ferroptosis and its related diseases
Shijian Feng, Dan Tang, Yichang Wang, et al.
Molecular Biomedicine (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 58
Iron Deposition in Parkinson’s Disease: A Mini-Review
Weiqi Zeng, Cai Jin, Lei Zhang, et al.
Cellular and Molecular Neurobiology (2024) Vol. 44, Iss. 1
Open Access | Times Cited: 20
Homeostasis and metabolism of iron and other metal ions in neurodegenerative diseases
Leilei Chen, Qingqing Shen, Yingjuan Liu, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 3
In defence of ferroptosis
Francesca M. Alves, Darius J.R. Lane, Triet Phu Minh Nguyen, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 2
Therapeutic Insights on Ferroptosis in Parkinson's disease
Komal Thapa, Heena Khan, Neha Kanojia, et al.
European Journal of Pharmacology (2022) Vol. 930, pp. 175133-175133
Closed Access | Times Cited: 53
Ferroptosis and Its Potential Role in the Nervous System Diseases
Yiyang Zhou, Wei Lin, T. Rajeswara Rao, et al.
Journal of Inflammation Research (2022) Vol. Volume 15, pp. 1555-1574
Open Access | Times Cited: 51
Pathogenesis of α-Synuclein in Parkinson’s Disease: From a Neuron-Glia Crosstalk Perspective
Shuanglong Yi, Linfang Wang, Honglei Wang, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 14753-14753
Open Access | Times Cited: 40
Mapping the Research of Ferroptosis in Parkinson’s Disease from 2013 to 2023: A Scientometric Review
Yingfan Chen, Zhenhui Wu, Shaodan Li, et al.
Drug Design Development and Therapy (2024) Vol. Volume 18, pp. 1053-1081
Open Access | Times Cited: 7
Unveiling the role of iPLA2β in neurodegeneration: From molecular mechanisms to advanced therapies
Jiabin Liu, Jieqiong Tan, Beisha Tang, et al.
Pharmacological Research (2024) Vol. 202, pp. 107114-107114
Open Access | Times Cited: 6
Inhibition of ferroptosis underlies EGCG mediated protection against Parkinson’s disease in a Drosophila model
Yanzhou Xia, Hongyan Wang, Zhongwen Xie, et al.
Free Radical Biology and Medicine (2023) Vol. 211, pp. 63-76
Closed Access | Times Cited: 15
A critical appraisal of ferroptosis in Alzheimer’s and Parkinson’s disease: new insights into emerging mechanisms and therapeutic targets
Priyanka Soni, Navneet Ammal Kaidery, Sudarshana M. Sharma, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 5
The Role and Mechanisms of Ubiquitin-Proteasome System-Mediated Ferroptosis in Neurological Disorders
Xin Liu, Wei Wang, Qunhua Nie, et al.
Neuroscience Bulletin (2025)
Closed Access
Identifying potential genes driving ferroptosis in the substantia nigra and dopaminergic neurons in Parkinson's disease
Arunaloke Chakrabarti, Sonia Verma
Molecular and Cellular Neuroscience (2025) Vol. 132, pp. 103993-103993
Closed Access
Deficient immunoproteasome assembly drives gain of α-synuclein pathology in Parkinson's disease
Mingxia Bi, Xixun Du, Xue Xiao, et al.
Redox Biology (2021) Vol. 47, pp. 102167-102167
Open Access | Times Cited: 27
The Relationship Between Protein S-Nitrosylation and Human Diseases: A Review
Yadi Zhang, Yuzhen Deng, Xiaoxi Yang, et al.
Neurochemical Research (2020) Vol. 45, Iss. 12, pp. 2815-2827
Closed Access | Times Cited: 31
Peiminine Reduces ARTS-Mediated Degradation of XIAP by Modulating the PINK1/Parkin Pathway to Ameliorate 6-Hydroxydopamine Toxicity and α-Synuclein Accumulation in Parkinson’s Disease Models In Vivo and In Vitro
Yu‐Ling Hsu, Huey‐Shan Hung, Chia-Wen Tsai, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 19, pp. 10240-10240
Open Access | Times Cited: 26
Roflupram attenuates α-synuclein-induced cytotoxicity and promotes the mitochondrial translocation of Parkin in SH-SY5Y cells overexpressing A53T mutant α-synuclein
Jiahong Zhong, Mengfan Li, Jiangping Xu, et al.
Toxicology and Applied Pharmacology (2022) Vol. 436, pp. 115859-115859
Closed Access | Times Cited: 17
Ferritinophagy and α-Synuclein: Pharmacological Targeting of Autophagy to Restore Iron Regulation in Parkinson’s Disease
Matthew K. Boag, Angus Roberts, Vladimir N. Uversky, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 4, pp. 2378-2378
Open Access | Times Cited: 17
Red clover (Trifolium pratense L.) extract inhibits ferroptotic cell death by modulating cellular iron homeostasis
Jun Pil Won, Eunsu Kim, Jinwoo Hur, et al.
Journal of Ethnopharmacology (2023) Vol. 308, pp. 116267-116267
Closed Access | Times Cited: 9
Parkinson’s Disease Dementia: Synergistic Effects of Alpha-Synuclein, Tau, Beta-Amyloid, and Iron
Jiajun Han, Yaohua Fan, Peipei Wu, et al.
Frontiers in Aging Neuroscience (2021) Vol. 13
Open Access | Times Cited: 21
Identifying the potential genes in alpha synuclein driving ferroptosis of Parkinson’s disease
Min Wang, T. Li, Rong Gao, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 7
Glutamic Acid Transporters: Targets for Neuroprotective Therapies in Parkinson’s Disease
Xiang Li, Wenjun Wang, Jianghong Yan, et al.
Frontiers in Neuroscience (2021) Vol. 15
Open Access | Times Cited: 13
Cadmium Through Disturbing MTF1-Mediated Metal Response Induced Cerebellar Injury
Shao-Shuai Bi, Milton Talukder, Haitao Jin, et al.
Neurotoxicity Research (2022) Vol. 40, Iss. 5, pp. 1127-1137
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top